Skip to main content
. 2023 Apr 29;59(5):865. doi: 10.3390/medicina59050865
MS Multiple sclerosis
pNfL Plasma neurofilament light chain
NEDA No evidence of disease activity
DMT Disease modifying therapy
MRI Magnetic resonance imaging
PIRA Progression independent of relapse activity
EDSS Expanded disability status scale
BVL Brain volume loss
RMS Relapsing multiple sclerosis
FUV Follow-up visit
SIMOA Single-molecule array
FLAIR Fluid-attenuated inversion recovery
WB Whole brain
GM Grey matter
AR-BVL Annual rate of brain volume loss
Gd Gadolinium
CI Confidence interval
ROC Receiver operating characteristics
AUC Area under curve
IQR Interquartile range
SD Standard deviation